IBM uses AI to evaluate risk of developing genetic diseases
In a study published in the journal Nature Communications, scientists at IBM, the Broad Institute of MIT and Harvard, and health tech company Color detail evidence that the presence of genetic mutations isn’t a reliable precursor to genetic diseases. They claim diseases can be so greatly influenced by other factors that the risk in carriers … Continue reading IBM uses AI to evaluate risk of developing genetic diseases
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed